HE INFLUENCE OF HIV INFECTION ON THE PROCESSES OF LUNG TISSUE REMODELING IN TUBERCULOSIS PATIENTS DURING ANTI-TB TREATMENT

Authors

  • Olga SHEVCHENKO Kharkiv National Medical
  • Liliia TODORIKO Bukovynian State Medical University
  • Helen TUDOR PMSI Institute of Pneumonology “Chiril Draganiuc”
  • Iryna OVCHARENKO Balti Medical College
  • Olga POHORIELOVA MNE of KRC “Regional Clinical Psychiatric Hospital No. 3
  • Sergiy OVCHARENKO Kharkiv National Medical

DOI:

https://doi.org/10.52692/1857-0011.2025.3-83.03

Keywords:

tuberculosis, HIV infection, Key words: tuberculosis, HIV infection,, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, oxyproline, aldosterone

Abstract

The adaptive immune response to tuberculosis develops approximately six weeks after infection. In HIV, this process is disrupted due to delayed activation of CD4 lymphocytes. Immune cells in combination with mycobacteria stimulate the synthesis of matrix metalloproteinase-9 (MMP-9), which breaks down collagen. Its breakdown product (hydroxyproline) is a biomarker of lung tissue destruction. The ratio of MMP-9 to tissue inhibitor of metalloproteinases-1 (TIMP-1) (MMP-9/TIMP-1) reflects the balance between degradation and repair of lung tissue. In addition, aldosterone plays an important role, as it can activate monocytes, enhance inflammation, disrupt fibrinolysis, and stimulate collagen synthesis by fibroblasts. Its elevated level is associated with the development of pulmonary fibrosis. In patients with MDR-TB without HIV infection, the processes of pulmonary tissue remodeling were more typical: the balance between MMP-9, TIMP-1, and hydroxyproline was maintained, which contributed to the development of fibrosis and limitation of inflammation. In patients with TB/HIV coinfection, there was a marked imbalance in fibrosis factors: increased levels of MMP-9 and hydroxyproline with insufficient activation of TIMP-1, which led to a more generalized process and worse clinical outcomes. Aldosterone levels decreased during treatment in both groups, but this decrease was less pronounced in TB/HIV patients, confirming abnormalities in the fibrosis system in this group of patients.

Author Biographies

Olga SHEVCHENKO, Kharkiv National Medical

doctor of medical sciences, univer. professor

Liliia TODORIKO, Bukovynian State Medical University

doctor of medical sciences, univer. professor

Helen TUDOR, PMSI Institute of Pneumonology “Chiril Draganiuc”

MD, PhD, member corr. of the AMSM

Iryna OVCHARENKO, Balti Medical College

MD, PhD, univer. teacher,

Olga POHORIELOVA, MNE of KRC “Regional Clinical Psychiatric Hospital No. 3

PhD, doctor

Sergiy OVCHARENKO, Kharkiv National Medical

PhD, univer. teacher,

References

Global tuberculosis report 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO.

HIV-Associated Tuberculosis. Available online: https://www.who.int/tb/areas-of-work/tb-hiv/tbhiv_factsheet.pdf

Sakai S, Mayer-Barber KD, Barber DL. Defining Features of Protective CD4 T cell responses to Mycobacterium tuberculosis. Current Opinion in Immunology. 2015;0:137-142.

Tornheim JA, Dooley KE. Tuberculosis Associated with HIV Infection. Microbiology Spectrum. 2017;5(1).

Auld SC, Staitieh BS. HIV and the tuberculosis “set point”: how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease. Retrovirology. 2020;32(17).

Kubler A, Luna B, Larsson C, Ammerman NC, Andrade BB, Orandle M, Bishai WR. Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation. Journal of Pathology. 2015;235(3):431- 444.

Shevchenko О.S, Todoriko L.D, Ovcharenko I.A, Pohorielova O.O, Shvets O.M. Analysis of changes in matrix metalloproteinases-9 and tissue inhibitors-1 levels in newly diagnosed pulmonary tb with different profile of drug-resistance. Tuberculosis, Lung Diseases, HIV Infection. 2022;3:5-10.

Shieh FK, Kotlyar E, Sam F. Aldosterone and cardiovascular remodelling: focus on myocardial failure. Journal of the Renin Angiotensin Aldosterone System. 2004;5(1):3-13.

Shevchenko OS, Todoriko LD, Ovcharenko IA, Radzishevska YB, Shvets OM, Ovcharenko SS, Semianiv IO, Vivsyannuk VV. Dynamics of aldosterone, connective tissue reorganization and glucose level as markers for tuberculosis treatment effectiveness. Archives of the Balkan Medical Union. 2019;54(2):274–280.

Hung C-S, Chou C-H, Liao C-W, Lan Y-T, Wu X-M, Chang Y-Y, et al. TAIPAI Study Group. Aldosterone Induces Tissue Inhibitor of Metalloproteinases-1 Expression and Further Contributes to Collagen Accumulation: From Clinical to Bench Studies. Hypertension. 2016;67(6):1309-1320.

Shevchenko OS, Ovcharenko IA, Todoriko LD. Pathophysiological mechanisms destruction of the lung connective tissue in tuberculosis. Infusion & Chamotherapy. 2019;2(2):14-20.

Amalinei C, Caruntu ID, Giusca SE, Bălan RA. Matrix metalloproteinases involvement in pathologic conditions. Romanian Journal of Morphology and Embryology. 2010;51(2):215-228.

Sabir N, Hussain T, Mangi MH, Zhao D, Zhou X. Matrix metalloproteinases: Expression, regulation and role in the immunopathology of tuberculosis. Cell Proliferation. 2019;52(4):e12649.

Published

2026-04-29

Issue

Section

Research Article

Categories